# PALBOCICLIB
> **ANDA214758** · Abbreviated New Drug Application (Generic) · Sponsor: MSN PHARMACEUTICALS INC · Approved 2023-04-12
## Drug
- **FDA Application Number:** ANDA214758
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PALBOCICLIB
- **Generic name:** Palbociclib
- **Active ingredients:** PALBOCICLIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MSN PHARMACEUTICALS INC
- **First approval:** 2023-04-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214758)
---
*AI Analytics · CC0 1.0*